import { Drug } from '@/types';

export const adhdData: Drug[] = [
  {
    id: 'methylphenidate',
    name: 'Methylphenidate',
    class: 'Stimulant (CNS)',
    mechanism: 'Blocks dopamine and norepinephrine reuptake. Increases synaptic DA and NE in prefrontal cortex, improving attention and impulse control.',
    indications: [
      'ADHD',
      'Narcolepsy',
    ],
    contraindications: [
      'Glaucoma',
      'Tics or Tourette syndrome (relative)',
      'MAOI use within 14 days',
      'Severe anxiety, agitation',
      'Hyperthyroidism',
    ],
    sideEffects: [
      'Decreased appetite, weight loss',
      'Insomnia',
      'Increased heart rate and blood pressure',
      'Irritability, mood changes',
      'Headache',
      'Growth suppression in children (with chronic use)',
      'Tics (can worsen)',
    ],
    interactions: [
      'MAOIs: hypertensive crisis',
      'Antihypertensives: may reduce efficacy',
    ],
    monitoring: [
      'Height and weight in children',
      'Blood pressure and heart rate',
      'ADHD symptoms',
      'Sleep',
      'Tics',
    ],
    dosing: {
      starting: '5 mg BID (IR); 18 mg daily (ER)',
      therapeutic: '20-60 mg daily in divided doses',
      maximum: '60 mg daily',
    },
    switchingNotes: [
      'Can switch between methylphenidate formulations',
      'Can switch to amphetamines if no response',
      'Consider non-stimulants if stimulants ineffective or not tolerated',
    ],
    warnings: [
      'Black box: High potential for abuse and dependence',
      'Cardiovascular screening recommended before initiating',
      'Monitor for growth suppression in children',
    ],
    specialPopulations: {
      pregnancy: 'Category C.',
      lactation: 'Excreted in milk; weigh risks.',
      geriatric: 'Limited data; monitor cardiovascular effects.',
      renal: 'No adjustment.',
      hepatic: 'No adjustment.',
    },
  },
  {
    id: 'amphetamine-dextroamphetamine',
    name: 'Amphetamine/Dextroamphetamine (Mixed Salts)',
    class: 'Stimulant (CNS)',
    mechanism: 'Increases release and blocks reuptake of dopamine and norepinephrine. Also inhibits MAO.',
    indications: [
      'ADHD',
      'Narcolepsy',
    ],
    contraindications: [
      'Advanced arteriosclerosis',
      'Symptomatic cardiovascular disease',
      'Moderate-severe hypertension',
      'Hyperthyroidism',
      'Glaucoma',
      'Agitated states',
      'MAOI use within 14 days',
    ],
    sideEffects: [
      'Decreased appetite, weight loss',
      'Insomnia',
      'Increased heart rate and blood pressure',
      'Irritability, agitation',
      'Headache',
      'Dry mouth',
      'Growth suppression in children',
    ],
    interactions: [
      'MAOIs: hypertensive crisis',
      'Urinary acidifiers/alkalinizers affect excretion',
    ],
    monitoring: [
      'Height and weight in children',
      'Blood pressure and heart rate',
      'ADHD symptoms',
      'Sleep',
      'Misuse potential',
    ],
    dosing: {
      starting: '5 mg daily or BID (IR); 10-20 mg daily (XR)',
      therapeutic: '20-30 mg daily',
      maximum: '40 mg daily (ADHD); 60 mg daily (narcolepsy)',
    },
    switchingNotes: [
      'Can switch between amphetamine formulations',
      'Can switch to methylphenidate if no response',
      'Consider non-stimulants if intolerable',
    ],
    warnings: [
      'Black box: High potential for abuse and dependence',
      'Cardiovascular screening recommended',
      'Monitor for growth suppression',
    ],
    specialPopulations: {
      pregnancy: 'Category C.',
      lactation: 'Excreted in milk; avoid.',
      geriatric: 'Use with caution.',
      renal: 'Caution.',
      hepatic: 'No specific adjustment.',
    },
  },
  {
    id: 'atomoxetine',
    name: 'Atomoxetine',
    class: 'Non-Stimulant (Selective NE Reuptake Inhibitor)',
    mechanism: 'Selective norepinephrine reuptake inhibitor. Increases NE in prefrontal cortex. Not a controlled substance.',
    indications: [
      'ADHD',
    ],
    contraindications: [
      'MAOI use within 14 days',
      'Narrow-angle glaucoma',
      'Pheochromocytoma',
    ],
    sideEffects: [
      'Decreased appetite, weight loss',
      'Nausea, vomiting',
      'Dizziness',
      'Fatigue, somnolence',
      'Mood swings, irritability',
      'Increased heart rate and blood pressure',
      'Sexual side effects',
      'Rare: hepatotoxicity, suicidal ideation',
    ],
    interactions: [
      'MAOIs',
      'CYP2D6 substrate (dose adjustment with strong inhibitors)',
    ],
    monitoring: [
      'Heart rate and blood pressure',
      'Mood and suicidal ideation (especially in youth)',
      'Liver function (if symptoms)',
      'Growth in children',
    ],
    dosing: {
      starting: '40 mg daily',
      therapeutic: '80 mg daily',
      maximum: '100 mg daily (or 1.4 mg/kg, whichever is less)',
    },
    switchingNotes: [
      'Delayed onset (2-4 weeks), unlike stimulants',
      'Good alternative if stimulant misuse concern or tics',
      'Can switch to stimulants if ineffective',
    ],
    warnings: [
      'Black box: Increased suicidal ideation in children and adolescents',
      'Rare severe liver injury',
      'Not as rapid-acting as stimulants',
    ],
    specialPopulations: {
      pregnancy: 'Category C.',
      lactation: 'Unknown; caution.',
      geriatric: 'Limited data.',
      renal: 'No adjustment.',
      hepatic: 'Reduce dose in hepatic impairment.',
    },
  },
  {
    id: 'guanfacine-xr',
    name: 'Guanfacine ER',
    class: 'Non-Stimulant (Alpha-2A Agonist)',
    mechanism: 'Alpha-2A adrenergic receptor agonist. Strengthens prefrontal cortex connections. Not a controlled substance.',
    indications: [
      'ADHD (monotherapy or adjunct to stimulants)',
    ],
    contraindications: [
      'Hypersensitivity',
    ],
    sideEffects: [
      'Somnolence, sedation',
      'Fatigue',
      'Hypotension',
      'Bradycardia',
      'Headache',
      'Irritability',
    ],
    interactions: [
      'CYP3A4 substrate',
      'Additive sedation with CNS depressants',
    ],
    monitoring: [
      'Blood pressure and heart rate',
      'Sedation',
      'Do not abruptly discontinue (rebound hypertension)',
    ],
    dosing: {
      starting: '1 mg daily',
      therapeutic: '1-4 mg daily',
      maximum: '4 mg daily',
    },
    switchingNotes: [
      'Often used adjunct to stimulants',
      'Alternative to stimulants if contraindicated',
      'Must taper off (do not stop abruptly)',
    ],
    warnings: [
      'Hypotension, bradycardia, syncope',
      'Rebound hypertension with abrupt discontinuation',
      'Sedation can be limiting',
    ],
    specialPopulations: {
      pregnancy: 'Category B.',
      lactation: 'Unknown; caution.',
      geriatric: 'Monitor cardiovascular effects.',
      renal: 'Caution.',
      hepatic: 'Caution.',
    },
  },
];
